Ethicon, Inc.
Clinical trials sponsored by Ethicon, Inc., explained in plain language.
A medical device company specializing in surgical products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New surgical patch aims to stop bleeding faster in open surgery Results expected Sep 2026 (estimated)
-
New patch stops bleeding fast in Kids' surgeries
Disease control CompletedThis study tested a patch called EVARREST that helps stop mild to moderate bleeding during open surgery in children. The patch contains natural proteins that help blood clot. In 35 children, the patch stopped bleeding quickly, often within 4 minutes. The results suggest it is a s…
Phase 3 • Sponsor: Ethicon, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New stitch tool tested in robot surgeries shows promise
Knowledge-focused CompletedThis study tested a special stitch device (STRATAFIX Spiral PDS Plus) used in robot-assisted surgeries for weight loss (sleeve gastrectomy) and hysterectomy. 161 adults took part. The main goal was to see how well it controlled bleeding after stitching. Doctors also rated how eas…
Sponsor: Ethicon, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC